Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of Peritoneal Lavage With Clindamycin-Gentamicin Solution & Oncologic Outcome

ABSTRACT: Antibiotic lavage reduces bacterial contamination and decreases SSI infection rate. SSI leads to an immunocompromised situation, leaving unattended the neoplasm. It has been described that SSI may result in a worse oncologic outcome.

DISEASE(S): Colorectal Tumors,Colorectal Neoplasms

PROVIDER: 2186565 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Effect of peritoneal lavage in elective colorectal surgery: a randomised trial

Project description:Interventions: perform the paritoneal lavage with 3,000ml of warm saline not perform the peritoneal lavage Primary outcome(s): rate of SSI Study Design: Parallel Randomized

| 2620410 | ecrin-mdr-crc

bronchoalceolar lavage

Project description:bronchoalceolar lavage Raw sequence reads

| PRJNA979827 | ENA

bronchoalveolar lavage fluid

Project description:bronchoalveolar lavage fluid Metagenome

| PRJNA449183 | ENA

Effect of Peritoneal Lavage With Clindamycin-gentamicin Solution on Postoperative Colorectal Cancer Infection in Elective Surgery

Project description:Intrabdominal antibiotic irrigation will reduce wound and intrabdominal infection.

| 2108583 | ecrin-mdr-crc

Segmental Allergen Challenge Regulates Gene Expression In Bronchoalveolar Lavage (BAL) Cells From Atopic and Mild Asthmatic Subjects

2013-05-01 | GSE46159 | GEO

Bronchoalveolar lavage, sputum, background

Project description:Bronchoalveolar lavage, sputum, background Metagenome

| PRJNA1003499 | ENA

Bronchoalveolar Lavage Fluid Pathogen Microbiology

Project description:Bronchoalveolar Lavage Fluid Pathogen Microbiology

| PRJEB72318 | ENA

Segmental Allergen Challenge Regulates Gene Expression In Bronchoalveolar Lavage (BAL) Cells From Atopic and Mild Asthmatic Subjects

Project description:Segmental allergen challenge increases the percentage of eosinophils in bronchoalveolar lavage (BAL) cells. Mepolizumab, an anti-IL-5 therapeutic antibody, decreases the number of eosinophils in bronchoalveolar lavages (BAL). The use of both procedures allows to define genes that are either expressed by eosinophils or dependent on eosinophil presence in the airways. Cells from Bronchoalveolar lavages (BAL) are obtained by bronchoscopy before (V5) and 48 h after a segmental allergen challenge (V6) in atopic and mild astmatics. This procedure was repeated in the same two subjects 2 months later and 1 month after an injection of mepolizumab (V22 is before challenge and V23 after challenge). Cells were immediately lysed and isolated total RNAs were analyzed using the Human Genome 1.0 ST GeneChip arrays (Affymetrix, Santa Clara, CA).

2013-05-01 | E-GEOD-46159 | biostudies-arrayexpress

Cytological findings of intraluminal lavage after colorectal endoscopic submucosal dissection

Project description:Primary outcome(s): exfoliated tumor cells of intraluminal lavage before and after(beginning of lavage, after lavage of 500ml,1000ml,1500ml) colorectal endoscopic submucosal dissection

| 2626421 | ecrin-mdr-crc

Clinical bronchoalveolar lavage (BAL) samples

Project description:Clinical bronchoalveolar lavage (BAL) samples Targeted loci

| PRJNA408304 | ENA